Senior Adviser, European Policy Centre, Adjunct Professor, Hertie School of Governance, Berlin This essay examines the state of the European Union post-eurozone crisis, and assesses the European ...
Colorectal cancer (CRC) is a leading global health concern, ranking as the third most diagnosed cancer and the second leading cause of cancer-related mortality. Historically, CRC has been ...
Off of the back of a film financing program revamp from the Hong Kong Film Development Council (HKFDC) in January earlier this year, Hong Kong’s upcoming Filmart will look to build on that ...
L’Oreal’s Effaclar Duo is an acne treatment product that has been recalled (Picture: Getty Images) A L’Oreal acne treatment cream and cleanser has been recalled over potential contamination ...
Colorectal cancer is the second-most common cause of cancer deaths in the United States A Rutgers student group has assembled more than 1,600 home test kits to spread a message about the importance of ...
From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...
As retirement approaches for many financial professionals, succession planning becomes critical—not just for the advisor, but for their clients as well. Canadian studies show that more than half of ...
Employees at the National Cancer Institute, which is part of the National Institutes of Health, received internal guidance last week to flag manuscripts, presentations or other communications for ...
CLAREMORE, Okla. — The Rogers County Cherokee Association (RCCA) hosted Troy Wayne Poteete, Executive Director the National Trail of Tears Association (NTOTA) at its regular monthly meeting on ...
LAKELAND, Fla. — Lakeland Regional Health (LRH) has repeatedly been ranked the second busiest emergency room department in the country. The hospital is expanding as Polk County continues to see ...
Marking Colorectal Cancer Awareness Month, TODAY’s Craig Melvin reports on the groundbreaking research from the Dana-Farber Cancer Institute that’s working to find cancer before it spreads.
Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses a new explanation for how cancer-fighting drugs attack and destroy BRCA1 and BRCA2 tumor cells.